Metraipolis › archive › dc_381b4afb336f

An alternating-intervention pilot trial on the impact of an informational handout on patient-reported outcomes and follow-up after lung cancer screening — Europe PMC PMID:38598511

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/38598511
DOI
10.1371/journal.pone.0300352
License (as archived)
CC0-1.0
Archived
2026-10-06T20:05:24.202Z
SHA-256 of the archived text
a6d800d3a74ea93b2a305c56852167e202becd14e5fcb902f09cda92112522a7
Stable URL of this page
https://metraipolis.com/documento/dc_381b4afb336f

How to cite

An alternating-intervention pilot trial on the impact of an informational handout on patient-reported outcomes and follow-up after lung cancer screening — Europe PMC PMID:38598511 — Europe PMC (en), https://europepmc.org/article/MED/38598511 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_381b4afb336f (Metraipolis archive dc_381b4afb336f, sha256 a6d800d3a74ea93b2a305c56852167e202becd14e5fcb902f09cda92112522a7)
BibTeX
@misc{dc381b4afb336f,
  title = {An alternating-intervention pilot trial on the impact of an informational handout on patient-reported outcomes and follow-up after lung cancer screening — Europe PMC PMID:38598511},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/38598511},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_381b4afb336f; sha256 a6d800d3a74ea93b2a305c56852167e202becd14e5fcb902f09cda92112522a7},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/38598511. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Introduction: Lung cancer screening (LCS) can reduce lung cancer mortality; however, poor understanding of results may impact patient experience and follow-up. We sought to determine whether an informational handout accompanying LCS results can improve patient-reported outcomes and adherence to follow-up. Study design: This was a prospective alternating intervention pilot trial of a handout to accompany LCS results delivery. Setting/participants: Patients undergoing LCS in a multisite program over a 6-month period received a mailing containing either: 1) a standardized form letter of LCS results (control) or 2) the LCS results letter and the handout (intervention). Intervention: A two-sided informational handout on commonly asked questions after LCS created through iterative mixed-methods evaluation with both LCS patients and providers. Outcome measures: The primary outcomes of 1)patient understanding of LCS results, 2)correct identification of next steps in screening, and 3)patient distress were measured through survey. Adherence to recommended follow-up after LCS was determined through chart review. Outcomes were compared between the intervention and control group using generalized estimating equations. Results: 389 patients were eligible and enrolled with survey responses from 230 participants (59% response rate). We found no differences in understanding of results, identification of next steps in follow-up or distress but did find higher levels of knowledge and understanding on questions assessing individual components of LCS in the intervention group. Follow-up adherence was overall similar between the two arms, though was higher in the intervention group among those with positive findings (p = 0.007). Conclusions: There were no differences in self-reported outcomes between the groups or overall follow-up adherence. Those receiving the intervention did report greater understanding and knowledge of key LCS components, and those with positive results had a higher rate of follow-up. This may represent a feasible component of a multi-level intervention to address knowledge and follow-up for LCS. Trial registration: ClinicalTrials.gov NCT05265897.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PloS one, 2024 (prima pubblicazione 2024-04-10).
Identificativi: PMID 38598511 · PMCID PMC11006146 · DOI 10.1371/journal.pone.0300352.
Descrittori MeSH principali: Lung Neoplasms.
Pagina: https://europepmc.org/article/MED/38598511 — https://doi.org/10.1371/journal.pone.0300352. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-06T18:30:56.316Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.